← Full program

  • Business of Medicine

Invention, Investment, and Invigoration (i3): Serving the Patient

Details

Date
Thursday, January 21, 2027
Time
7:00 AM – 5:00 PM
Room
Milano Ballroom I & II
Session type
Pre-Conference Session
Schedule
See this day

About

This full-day pre-conference course will provide a comprehensive overview of the evolving neuromodulation ecosystem, organized around the central theme of serving the patient. Bringing together leaders from academia, industry, and investment, the program will explore the field from technological innovation through commercialization and clinical adoption. Sessions will examine the future of neuromodulation, the funding outlook for emerging startups, and advances in key areas including brain-computer interfaces, neuromodulation for internal organs, and emerging modalities such as ultrasound-based stimulation. Additional discussion will address the critical role of reimbursement and evidence generation in ensuring patient access to new therapies. The course will conclude with a panel featuring senior leaders from major neuromodulation companies sharing perspectives on industry trends and future opportunities. Designed to encourage cross-sector dialogue, the program aims to highlight how scientific, clinical, and business decisions ultimately converge around a common goal: improving outcomes and access for patients.

Learning objectives

  • Identify emerging neuromodulation technologies such as BCI, organ neuromodulation, and ultrasound stimulation and their potential clinical impact.
  • Understand the innovation pathway from startup funding and technology development to commercialization in neuromodulation.
  • Recognize key factors affecting patient access, including clinical evidence, reimbursement, and industry strategy.

Faculty

Presentations